BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11266449)

  • 1. Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1.
    Keilhack H; Müller M; Böhmer SA; Frank C; Weidner KM; Birchmeier W; Ligensa T; Berndt A; Kosmehl H; Günther B; Müller T; Birchmeier C; Böhmer FD
    J Cell Biol; 2001 Jan; 152(2):325-34. PubMed ID: 11266449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.
    Yang W; Tabrizi M; Berrada K; Yi T
    Blood; 1998 May; 91(10):3746-55. PubMed ID: 9573011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
    Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
    J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of SHP-1-target interaction.
    Biskup C; Böhmer A; Pusch R; Kelbauskas L; Gorshokov A; Majoul I; Lindenau J; Benndorf K; Böhmer FD
    J Cell Sci; 2004 Oct; 117(Pt 21):5165-78. PubMed ID: 15456853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.
    Jiao H; Berrada K; Yang W; Tabrizi M; Platanias LC; Yi T
    Mol Cell Biol; 1996 Dec; 16(12):6985-92. PubMed ID: 8943354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
    Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
    Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
    Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
    Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
    Li C; Friedman JM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages.
    Berg KL; Siminovitch KA; Stanley ER
    J Biol Chem; 1999 Dec; 274(50):35855-65. PubMed ID: 10585470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the hematopoietic cell phosphatase (Hcph) gene is associated with resistance to gamma-irradiation-induced apoptosis in Src homology protein tyrosine phosphatase (SHP)-1-deficient "motheaten" mutant mice.
    Hsu HC; Shultz LD; Su X; Shi J; Yang PA; Relyea MJ; Zhang HG; Mountz JD
    J Immunol; 2001 Jan; 166(2):772-80. PubMed ID: 11145649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
    Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
    Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
    Tang H; Zhao ZJ; Landon EJ; Inagami T
    J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient association of the phosphotyrosine phosphatase SHP-2 with TrkA is induced by nerve growth factor.
    Goldsmith BA; Koizumi S
    J Neurochem; 1997 Sep; 69(3):1014-9. PubMed ID: 9282923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
    Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
    Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction.
    Haque SJ; Harbor P; Tabrizi M; Yi T; Williams BR
    J Biol Chem; 1998 Dec; 273(51):33893-6. PubMed ID: 9852037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
    Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
    Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.